Cancer-Channel Icon 

Recently, the heterogeneity and complexity of malignant tumors has changed the way we think about the initiation, progression, diagnosis, and management of cancer. The Cancer Channel will explore the emerging molecular markers, improved preclinical models, and genomic-based therapies that are increasing the success of personalized medicine.

Cancer Molecular Markers

Circulating Tumor Cells

Translational to Clinical R&D

Technology-Driven Oncology Clinical Development

Predictive Preclinical Models in Oncology


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 


2015 Brochure cover 

Premier Sponsors:

Abbott Molecular 




Jackson Laboratory - small logo 

Leica Biosystems 



Silicon Biosystems 



Thomson Reuters-Large